Skip to content

Effects of intravenous dextrose 5% on delivery

Comparing parenteral 5% dextrose, ringer and oral intake on the duration of labor stages in nulliparous women: A double- blinded randomized, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201602213027N35
Enrollment
201
Registered
2016-03-13
Start date
2016-03-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery. O80-O84

Interventions

Intervention 1: 5% dextrose injection experimental group serum: serum administered dextrose 5% at a speed of 125 ml per hour in nulliparous women with vaginal delivery. Intervention 2: The interventio
Treatment - Drugs
5% dextrose injection experimental group serum: serum administered dextrose 5% at a speed of 125 ml per hour in nulliparous women with vaginal delivery
The intervention group injected Ringer: Ringer prescribed speed of 125 ml per hour in nulliparous women with vaginal delivery
The control group received only oral liquid

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: being nulliparous, ages 18-35, gestational age (38-41 weeks), singleton pregnancy with cephalic presentation, onset of first stage of labor and 3-4 cm dilated, spontaneous onset of labor, maternal first trimester body mass index 18.5 <BMI<24.9 kg/m2, normal maternal pelvis (according to the experts and the researchers examinations), clinical and ultrasound prediction of no fetal macrosomia (weight more than 4.5 kg). Exclusion criteria: women with labor induction (indications of induction of labor such as prolonged rupture of membranes (over 18 h), gestational hypertension, nonreassuring fetal status, diabetes or preeclampsia), high risk pregnancies (gestational diabetes, preeclampsia, heart or kidney diseases, IUGR, detachment or placenta praevia,. ..) evidence of chorioamnionitis (maternal fever over 38oc) and fetal distress (abnormal NST), intrauterine fetal death, use of epidural

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total of first stage of delivery. Timepoint: Since intervention to full dilatation. Method of measurement: Timer.;Total of Second stage of delivery. Timepoint: Full Dilatation to delivery. Method of measurement: Timer.;Total of Third stage of delivery. Timepoint: From birth to Exit placenta. Method of measurement: Timer.

Secondary

MeasureTime frame
Maternal outcomes (delivery type, frequency of use of oxytocin, the frequency of prolonged labor). Timepoint: Start deliveries until the end of maternity. Method of measurement: check list.;Neonatal outcome (Apgar score). Timepoint: Immediately after delivery. Method of measurement: check list.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ahadi Yulgunlu

Farzane Shahmohammadi

fatemehahadi8@gmail.com+98 44 4532 2868

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026